Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis.
about
Selective depletion of tumor neovasculature by microbubble destruction with appropriate ultrasound pressureData Mining as a Powerful Tool for Creating Novel Drugs in Cardiovascular Medicine: The Importance of a "Back-and-Forth Loop" Between Clinical Data and Basic Research.Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion.HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-OverloadHistamine deficiency exacerbates myocardial injury in acute myocardial infarction through impaired macrophage infiltration and increased cardiomyocyte apoptosisLoss of CEACAM1, a Tumor-Associated Factor, Attenuates Post-infarction Cardiac Remodeling by Inhibiting Apoptosis.Multi-Strain Probiotics Inhibit Cardiac Myopathies and Autophagy to Prevent Heart Injury in High-Fat Diet-Fed Rats.Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study.FGF23 promotes myocardial fibrosis in mice through activation of β-catenin.Aggravated myocardial infarction-induced cardiac remodeling and heart failure in histamine-deficient mice.Current Knowledge and Perspectives on Histamine H1 and H2 Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands.Associations of Polymorphisms in HRH2, HRH3, DAO, and HNMT Genes with Risk of Chronic Heart Failure.Mast Cells: Key Contributors to Cardiac Fibrosis.Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial).H2-receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.Cardioprotective effect of histamine H2 antagonists in congestive heart failure: A systematic review and meta-analysis.Use of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study.
P2860
Q30356174-97B2515C-61B2-493F-8334-4870F42B3926Q30975654-BEEEF5CE-AE60-4D35-8B58-2A10303AF3E4Q35693011-E87515C1-3DCD-4A81-BE14-239F3B0785F6Q36063836-CAAAC3FB-9529-48D2-A1D4-CBF59155DDF5Q36273598-633D1CE5-AA74-48D1-A1D3-9FC3E8BC3080Q36615801-D479908F-D201-4D94-A28A-307E621858CEQ36792321-FF6E1616-F1E4-4D27-8814-A1EE5876AF15Q36881933-0FEFA985-D2EA-46DB-8206-7DBD9CE2E860Q37662106-7899ABFA-2549-4A24-A0D8-8B086E89634CQ37685771-FBCF0755-C49B-4ADF-8DE2-F1441D6F1CAAQ38953768-E506D5E6-1394-44B7-A475-488FA78504F6Q41811474-FECE3D6A-7B0A-4CE1-809B-0EC176699720Q48253413-407CBF6A-A52A-4B03-A2C9-D0285F6585FCQ49389901-CC5952E8-9733-4A87-8B2E-58BE338E2267Q50044701-2A58E370-4341-46B7-97E7-A6424C820314Q52593831-5E4D6ECB-ACA0-4433-84EC-F5A0B8D6884EQ55261208-2EC81CA0-116F-4B36-8D2E-DAF8D2388BA9
P2860
Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@en
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@nl
type
label
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@en
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@nl
prefLabel
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@en
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Disruption of histamine H2 rec ...... ardial apoptosis and fibrosis.
@en
P2093
Jianping Bin
Jingwen Zhang
Liang Shen
Masafumi Kitakaze
Shiping Cao
Xiaobo Huang
Yasushi Fukushima
P2860
P304
P356
10.1042/CS20130716
P407
P50
P577
2014-10-01T00:00:00Z